Curanex PharmaceuticalsCURX
13F holders, Q3 2025 (September 30)10holders
2famous investors
$0.72avg. 13F price*
At the end of Q3 2025, 10 institutions reported holding Curanex Pharmaceuticals Inc. (CURX) in their 13F filings. The largest holders were UBS Group AG ($46K), Citadel Advisors ($46K) and Jane Street Group, LLC ($25K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Curanex Pharmaceuticals Inc.
- CUSIP
- 23126K106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $206K |
| Exits | 0 | $0 |
Ownership 10 holders
| UBS Group AG | 0.00% | New | 64,516 | $46K |
| Citadel Advisors | 0.00% | New | 64,067 | $46K |
| Jane Street Group, LLC | 0.00% | New | 35,277 | $25K |
| Two Sigma Securities, LLC | 0.00% | New | 32,435 | $23K |
| Jump Financial, LLC | 0.00% | New | 27,200 | $20K |
| Millennium Management | 0.00% | New | 19,154 | $14K |
| Geode Capital Management, LLC | 0.00% | New | 18,670 | $13K |
| Scientech Research LLC | 0.00% | New | 14,480 | $10K |
| Osaic Holdings, Inc. | 0.00% | New | 5,700 | $4K |
| Barclays PLC | 0.00% | New | 4,594 | $3K |
"% of holder's portfolio" is CURX's weight in each manager's 13F, not the share of Curanex Pharmaceuticals Inc. the manager owns.